Florbetapir F 18

CHEMBL1774461 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
359.4 g/mol
LogP
3.5
Phase
4

This radioactive imaging agent binds to beta-amyloid plaques in the brain and is used with PET scanning to help diagnose Alzheimer's disease. It provides visual information about amyloid burden that can support clinical evaluation in patients with cognitive impairment.

Khối lượng phân tử

359,4000 g/mol

LogP

3,50

TPSA

52,60 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1

InChI

InChI=1S/C20H25FN2O3/c1-22-19-7-4-17(5-8-19)2-3-18-6-9-20(23-16-18)26-15-14-25-13-12-24-11-10-21/h2-9,16,22H,10-15H2,1H3/b3-2+/i21-1

Molecular Formula

C20H25FN2O3

HBD / HBA

1 / 6

Liên kết có thể quay

12

Nguyên tử nặng

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This radioactive imaging agent binds to beta-amyloid plaques in the brain and is used with PET scanning to help diagnose Alzheimer's disease. It provides visual information about amyloid burden that can support clinical evaluation in patients with cognitive impairment.

Yes, Florbetapir F 18 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1774461. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24822371. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.